Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Carnitine in type 2 diabetes.

Geltrude Mingrone1

  • 1Department of Internal Medicine, Catholic University, School of Medicine, 00135 Roma, Italy. gmingrone@rm.unicatt.it

Annals of the New York Academy of Sciences
|December 14, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Endoluminal device induces insulin sensitivity and greater weight control than semaglutide in pigs.

Gut·2026
Same author

Correction: Post-Operative Safety Outcomes and 5-Year Healthcare Utilisation After Bariatric Surgery vs. Other Elective Types of Surgical Treatments - A Retrospective Observational Cohort Study.

Obesity surgery·2026
Same author

Post-Operative Safety Outcomes and 5-Year Healthcare Utilisation After Bariatric Surgery vs. Other Elective Types of Surgical Treatments - A Retrospective Observational Cohort Study.

Obesity surgery·2026
Same author

Personalizing bariatric metabolic surgery: Predictors of weight-loss success and risk of weight recurrence.

Metabolism: clinical and experimental·2026
Same author

Impact of overweight and obesity on fasting insulin secretion in men and women without diabetes: effect sizes and mechanisms.

Diabetologia·2025
Same author

Cost-effectiveness analysis of surgical and non-surgical weight loss interventions in end-stage knee osteoarthritis and obesity: a Markov State model.

BMC public health·2025

Carnitine and acetyl-L-carnitine improve glucose metabolism in healthy individuals and type 2 diabetic patients. These compounds enhance insulin-mediated glucose disposal by regulating cellular fuel transport and enzyme synthesis.

Area of Science:

  • Biochemistry
  • Metabolic Science
  • Endocrinology

Background:

  • Carnitine is essential for lipid metabolism, facilitating fatty acid transport into mitochondria for beta-oxidation.
  • Carnitine also plays a role in glucose metabolism and fuel sensing by shuttling acetyl groups.
  • Reduced carnitine function can lead to triglyceride accumulation and insulin resistance.

Purpose of the Study:

  • To investigate the effects of L-carnitine and acetyl-L-carnitine (ALC) on glucose metabolism.
  • To determine if carnitine supplementation improves insulin-mediated glucose disposal in healthy subjects and type 2 diabetic patients.

Main Methods:

  • Administered L-carnitine and ALC to healthy volunteers and type 2 diabetic patients.
  • Utilized euglycemic hyperinsulinemic clamp studies to measure glucose disposal.

Related Experiment Videos

  • Employed minimal modeling of glucose kinetics for detailed analysis.

    • Main Results:

    • Acute hypercarnitinemia stimulated nonoxidative glucose disposal in healthy volunteers and type 2 diabetic patients.
    • Acetyl-L-carnitine administration significantly increased glucose tissue uptake without a clear dose-response effect.
    • Both L-carnitine and ALC demonstrated efficacy in improving insulin-mediated glucose disposal.

    Conclusions:

    • L-carnitine and ALC are effective in enhancing insulin-mediated glucose disposal in both healthy and type 2 diabetic individuals.
    • Potential mechanisms include regulation of acetyl and acyl cellular trafficking and control of glycolytic/gluconeogenic enzyme synthesis.
    • Carnitine supplementation shows promise for metabolic health and managing glucose homeostasis.